• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ASCENSIA DIABETES CARE US INC. CONTOUR NEXT; QUALITY CONTROL MATERIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ASCENSIA DIABETES CARE US INC. CONTOUR NEXT; QUALITY CONTROL MATERIAL Back to Search Results
Model Number 7314
Medical Device Problem Code Incorrect, Inadequate or Imprecise Result or Readings (1535)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 09/16/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The customer returned the suspected contour next gen meter, contour next test strips associated with the event and contour next control solution from lot # 4bv2g26 for evaluation.An in-house testing was performed with the returned meter, test strips and control solution, which gave a satisfactory performance.The control readings obtained with the in-house testing were properly marked as control tests in the meter's memory.The patient/family (a1) was the initial reporter (e1), so personal information was not entered.No information was captured in section a4 as the customer's weight was not provided.
 
Event or Problem Description
The customer reported that he ran control tests with the contour next gen meter and obtained readings of 189 mg/dl at 12:40 p.M., 138 mg/dl 12:51 p.M., 134 mg/dl 12:55 p.M., 153 mg/dl 12:56 p.M., and 204 mg/dl at 12:59 p.M.The meter did not automatically mark them as control tests, and so the readings will be displayed as blood results when accessing the meter's memory.There was no allegation of an adverse event.A replacement meter kit was sent to the customer.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONTOUR NEXT
Common Device Name
QUALITY CONTROL MATERIAL
Manufacturer (Section D)
ASCENSIA DIABETES CARE US INC.
100 summit lake drive
valhalla NY 10595
Manufacturer (Section G)
BIONOSTICS, INC. BUSINESS TRADE NAME: RNA MEDICAL
registration number: 1220649
7 jackson rd.
devens MA 01434
Manufacturer Contact
shweta gulati
100 summit lake drive
valhalla, NY 10595
9142361830
MDR Report Key20453620
Report Number1810909-2024-00157
Device Sequence Number12915569
Product Code JJX
UDI-Device Identifier10301937314015
UDI-Public10301937314015
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
K151742
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Consumer
Initial Reporter Occupation Other
Remedial Action Replace
Type of Report Initial
Report Date (Section B) 09/16/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date09/30/2025
Device Model Number7314
Device Lot Number4BV2G26
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/24/2024
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 09/16/2024
Initial Report FDA Received Date10/15/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured03/01/2024
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Unknown
Patient Sequence Number1
Patient Age77 YR
Patient SexMale
-
-